Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (141-150 of 464) with videos related to

Pageof 47
Sort By:
Plos One|February 2, 2018
RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibitionPhilip Earwaker, Caroline Anderson, Frances Willenbrock, et al.
Gynecologic Oncology|July 14, 2006
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosisAlexandra Giatromanolaki, Efthimios Sivridis, Kevin C Gatter, et al.
Breast Cancer Research : BCR|October 29, 2003
Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosisZoë E Winters, Russell D Leek, Mike J Bradburn, et al.
Cancer Research|October 16, 2003
Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxiaHeidi M Sowter, Raju R Raval, John W Moore, et al.
Cancer Research|December 4, 2002
A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell linesTsung Wen Chong, Lawrence D Horwitz, John W Moore, et al.
International Journal of Oncology|May 5, 2005
Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell deathMartin Raida, Joachim H Clement, Kurosh Ameri, et al.
Pharmaceuticals (Basel, Switzerland)|April 21, 2015
Does amifostine reduce metabolic rate? Effect of the drug on gas exchange and acute ventilatory hypoxic response in humansJaideep J Pandit, Caroline Allen, Evelyn Little, et al.
Cancer Research|September 18, 2004
c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanismUlrike E Knies-Bamforth, Stephen B Fox, Richard Poulsom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradationDylan T Jones, Christopher W Pugh, Simon Wigfield, et al.
Biochemical Pharmacology|January 27, 2010
Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinaseHoward R Mellor, Kasper M Rouschop, Simon M Wigfield, et al.
Pageof 47

Showing results (141-150 of 464) with videos related to

Sort By:
Pageof 47
Plos One|February 2, 2018
RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibitionPhilip Earwaker, Caroline Anderson, Frances Willenbrock, et al.
Gynecologic Oncology|July 14, 2006
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosisAlexandra Giatromanolaki, Efthimios Sivridis, Kevin C Gatter, et al.
Breast Cancer Research : BCR|October 29, 2003
Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosisZoë E Winters, Russell D Leek, Mike J Bradburn, et al.
Cancer Research|October 16, 2003
Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxiaHeidi M Sowter, Raju R Raval, John W Moore, et al.
Cancer Research|December 4, 2002
A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell linesTsung Wen Chong, Lawrence D Horwitz, John W Moore, et al.
International Journal of Oncology|May 5, 2005
Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell deathMartin Raida, Joachim H Clement, Kurosh Ameri, et al.
Pharmaceuticals (Basel, Switzerland)|April 21, 2015
Does amifostine reduce metabolic rate? Effect of the drug on gas exchange and acute ventilatory hypoxic response in humansJaideep J Pandit, Caroline Allen, Evelyn Little, et al.
Cancer Research|September 18, 2004
c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanismUlrike E Knies-Bamforth, Stephen B Fox, Richard Poulsom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradationDylan T Jones, Christopher W Pugh, Simon Wigfield, et al.
Biochemical Pharmacology|January 27, 2010
Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinaseHoward R Mellor, Kasper M Rouschop, Simon M Wigfield, et al.
Pageof 47